Literature DB >> 18453281

The epidemiological transition: the current status of infectious diseases in the developed world versus the developing world.

John W Sanders1, Greg S Fuhrer, Mark D Johnson, Mark S Riddle.   

Abstract

Wealthy, industrialized countries of the developed world successfully underwent the "epidemiologic transition" from infectious diseases to degenerative diseases, but developing countries have not yet achieved that transition. This article reviews the current status of Omran's Theory of Epidemiologic Transition, comparing the burden of infectious diseases in the developed world versus the developing world. The advent of modern sanitation and hygiene practices, effective vaccines, and antibiotics have significantly diminished the burden in the developed world, but infectious diseases remain the most common cause of death worldwide. The persistence of this disease burden has been due to a failure to employee effective strategies and to unforeseen developments, such as the emergence of HIV and the re-emergence of malaria and tuberculosis driven by newly developed drug resistance. The challenge in accurately assessing infectious disease burden and developing effective interventions is reviewed along with the most common diseases and current intervention strategies.

Entities:  

Mesh:

Year:  2008        PMID: 18453281     DOI: 10.3184/003685008X284628

Source DB:  PubMed          Journal:  Sci Prog        ISSN: 0036-8504            Impact factor:   2.774


  14 in total

1.  Assessment of malaria in vitro drug combination screening and mixed-strain infections using the malaria Sybr green I-based fluorescence assay.

Authors:  Edgie-Mark A Co; Richard A Dennull; Drew D Reinbold; Norman C Waters; Jacob D Johnson
Journal:  Antimicrob Agents Chemother       Date:  2009-04-06       Impact factor: 5.191

2.  Triangulating on success: innovation, public health, medical care, and cause-specific US mortality rates over a half century (1950-2000).

Authors:  George Rust; David Satcher; George Edgar Fryer; Robert S Levine; Daniel S Blumenthal
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

3.  Infectious Gastroenteritis as a Risk Factor for Tropical Sprue and Malabsorption: A Case-Control Study.

Authors:  Matthew G McCarroll; Mark S Riddle; Ramiro L Gutierrez; Chad K Porter
Journal:  Dig Dis Sci       Date:  2015-06-27       Impact factor: 3.199

Review 4.  Reviewing the Past, Present, and Future Risks of Pathogens in Ghana and What This Means for Rethinking Infectious Disease Surveillance for Sub-Saharan Africa.

Authors:  Peter N-Jonaam Mahama; Amos Tiereyangn Kabo-Bah; Justine I Blanford; Edmund Ilimoan Yamba; Prince Antwi-Agyei
Journal:  J Trop Med       Date:  2022-07-14

5.  In search of a germ theory equivalent for chronic disease.

Authors:  Garry Egger
Journal:  Prev Chronic Dis       Date:  2012-05-10       Impact factor: 2.830

6.  The evolution of disease: anthropological perspectives on epidemiologic transitions.

Authors:  Molly Kathleen Zuckerman; Kristin Nicole Harper; Ronald Barrett; George John Armelagos
Journal:  Glob Health Action       Date:  2014-05-15       Impact factor: 2.640

7.  Understanding the development and perception of global health for more effective student education.

Authors:  Xinguang Chen
Journal:  Yale J Biol Med       Date:  2014-09-03

8.  Surgeons and preventative health: protocol for a mixed methods study of current practice, beliefs and attitudes influencing health promotion activities amongst public hospital surgeons.

Authors:  Stephen Barrett; Stephen Begg; Michael Kingsley
Journal:  BMC Health Serv Res       Date:  2018-10-16       Impact factor: 2.655

Review 9.  Beyond obesity and lifestyle: a review of 21st century chronic disease determinants.

Authors:  Garry Egger; John Dixon
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

10.  Global nursing in an Ebola viral haemorrhagic fever outbreak: before, during and after deployment.

Authors:  Eva von Strauss; Stéphanie Paillard-Borg; Jessica Holmgren; Panu Saaristo
Journal:  Glob Health Action       Date:  2017       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.